NBO Pharma Inc.

CIK 2103906 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NBO Pharma Inc..

Recent SEC filings

FiledFormAccession number
Jan 22, 2026D0002103906-26-000001